Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe - a Hungarian nationwide observational study
Authors:
- Pál MihellerPMPál Miheller
- Péter L LakatosPLPéter L Lakatos
- Gábor HorváthGHGábor Horváth
- Tamás MolnárTMTamás Molnár
- Tamás SzamosiTSTamás Szamosi
- Zsófia CzeglédiZCZsófia Czeglédi
- Ágnes SalamonÁSÁgnes Salamon
- József CzimmerJCJózsef Czimmer
- György RumiGRGyörgy Rumi
- Károly PalatkaKPKároly Palatka
- Mária PappMPMária Papp
- Zsolt JakabZJZsolt Jakab
Open Access
- 10 September 2009
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 9 (1) , 66
Abstract
Infliximab (IFX) has proven to be an effective addition to the therapeutic arsenal for refractory, fistulizing, and steroid dependent Crohn's disease (CD), with efficacy in the induction and maintenance of clinical remission of CD. Our objective in this study is to report the nationwide, multicenter experience with IFX induction therapy for CD in Hungary.Keywords
This publication has 19 references indexed in Scilit:
- Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohortGut, 2008
- A Randomized Trial of Methotrexate in Combination With Infliximab for the Treatment of Crohn's DiseaseGastroenterology, 2008
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2005
- Infliximab in the treatment of Crohn's disease: Predictors of response in an Italian multicentric open studyDigestive and Liver Disease, 2005
- Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statementDigestive and Liver Disease, 2005
- Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn’s diseaseGastroenterology, 2005
- Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's diseaseAmerican Journal of Gastroenterology, 2002
- Infliximab Treatment for Crohn's Disease: One-Year Experience in a Dutch Academic HospitalInflammatory Bowel Diseases, 2002
- Efficacy and safety of repeated infliximab infusions for Crohn's disease: 1-year clinical experienceInflammatory Bowel Diseases, 2001
- Clinical Experience With Infliximab Therapy in 100 Patients With Crohn's DiseaseAmerican Journal of Gastroenterology, 2000